Yonhap Infomax NewsGC Genome's planned dual listing has sparked concerns over conflicts of interest between parent and subsidiary shareholders due to high intra-group transactions, with experts warning of potential negative impacts on share price and the Korea Discount.
#YonhapInfomax #GCGenome #DualListing #InternalTransactions #KoreaDiscount #ShareholderConflict #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65339
#YonhapInfomax #GCGenome #DualListing #InternalTransactions #KoreaDiscount #ShareholderConflict #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65339
[GC Genome Listingā£] Parent-Subsidiary Conflict of Interest Issues
GC Genome's planned dual listing has sparked concerns over conflicts of interest between parent and subsidiary shareholders due to high intra-group transactions, with experts warning of potential negative impacts on share price and the Korea Discount.